Actively Recruiting
GnRH Agonist for Dual Trigger in IVF and for Luteal Phase Support in FET
Led by The University of Hong Kong · Updated on 2024-12-06
784
Participants Needed
1
Research Sites
291 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The objectives of this study are to compare the efficacy of the dual trigger group vs the hCG trigger group on the live birth rate in women undergoing IVF and the efficacy of the agonist in LP group vs the placebo group on the live birth rate in women undergoing FET.
CONDITIONS
Official Title
GnRH Agonist for Dual Trigger in IVF and for Luteal Phase Support in FET
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women aged <43 years at the time of IVF treatment
- Replacing early cleavage embryos or blastocysts after thawing in FET
- FET in natural cycles
You will not qualify if you...
- Preimplantation genetic diagnosis treatment
- Use of donor oocytes or donor embryos
- Hydrosalpinx shown on pelvic scanning and not surgically treated
- Women at risk of OHSS
- Frozen early cleavage embryos thawed and cultured to blastocysts prior to transfer as requested by the patient
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of Obstetrics and Gynaecology
Hong Kong, Hong Kong, China
Actively Recruiting
Research Team
E
Ernest HY Ng, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here